Richard Morgan

Richard has played an active role in the development of more than 35 life science and technology companies, including MediSense, Quidel, Celgene (all listed on NASDAQ) and, most recently, Kromek Group, MotifBio and Polarean Imaging, each of which was listed on the London Stock Exchange. Richard co-founded Celgene in 1987 and was on the board for 20 years, serving as Chairman and CEO before recruiting a new CEO. He was Founder and Chief Executive Officer of Amphion Innovations plc. Prior to founding Amphion, he was a Managing Partner at Wolfensohn Partners LP, which followed 15 years at Schroders plc, then a leading British merchant bank. Richard is a Managing Partner at Twiga Group LLC.